Phase II Study on Safety of 60 Days Administration of Triticum Monococcum in Patients With Celiac Disease on Remission in ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2010-2011

ABSTRACT

Preliminary studies on safety profile of Triticum Monococcum (Tm, a variety of Ancient Wheat) have provided conflicting results with some in vitro and ex vivo studies consistent with non toxicity and other suggestive of toxicity. We recently reported results of a single administration of 2.5 grams of Tm in 12 Celiacs in remission on Gluten Free Diet (GFD), while assessing symptoms and changes of intestinal permeability. Although results of intestinal permeability were inconclusive Tm, but not other type of gluten, was clinically well tolerated. The aim of the present study was to assess safety of 60 days of administration of Tm (100 grams of water biscuits per day accounting for about 6 grams of gluten from Tm) as judged on clinical, serological and histological parameters in Celiac Disease patients on remission after 1 year of GFD. More... »

URL

https://clinicaltrials.gov/show/NCT02220166

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Preliminary studies on safety profile of Triticum Monococcum (Tm, a variety of Ancient Wheat) have provided conflicting results with some in vitro and ex vivo studies consistent with non toxicity and other suggestive of toxicity. We recently reported results of a single administration of 2.5 grams of Tm in 12 Celiacs in remission on Gluten Free Diet (GFD), while assessing symptoms and changes of intestinal permeability. Although results of intestinal permeability were inconclusive Tm, but not other type of gluten, was clinically well tolerated. The aim of the present study was to assess safety of 60 days of administration of Tm (100 grams of water biscuits per day accounting for about 6 grams of gluten from Tm) as judged on clinical, serological and histological parameters in Celiac Disease patients on remission after 1 year of GFD.", 
    "endDate": "2011-08-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT02220166", 
    "keywords": [
      "Phase II", 
      "safety", 
      "Triticum", 
      "celiac disease", 
      "gluten-free diet", 
      "preliminary study", 
      "safety profile", 
      "TM", 
      "vitro", 
      "ex vivo study", 
      "toxicity", 
      "reported result", 
      "single administration", 
      "Gram", 
      "remission", 
      "symptom", 
      "intestinal permeability", 
      "gluten", 
      "present study", 
      "Organization and Administration", 
      "biscuit", 
      "parameter", 
      "patient"
    ], 
    "name": "Phase II Study on Safety of 60 Days Administration of Triticum Monococcum in Patients With Celiac Disease on Remission in Gluten Free Diet", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT02220166"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00017.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.7637.5", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.412725.7", 
        "type": "Organization"
      }
    ], 
    "startDate": "2010-11-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/1471-230x-13-92", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030901615", 
          "https://doi.org/10.1186/1471-230x-13-92"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT02220166"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT02220166'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT02220166'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT02220166'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT02220166'


 

This table displays all metadata directly associated to this object as RDF triples.

48 TRIPLES      16 PREDICATES      40 URIs      32 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT02220166 schema:about anzsrc-for:3103
2 schema:description Preliminary studies on safety profile of Triticum Monococcum (Tm, a variety of Ancient Wheat) have provided conflicting results with some in vitro and ex vivo studies consistent with non toxicity and other suggestive of toxicity. We recently reported results of a single administration of 2.5 grams of Tm in 12 Celiacs in remission on Gluten Free Diet (GFD), while assessing symptoms and changes of intestinal permeability. Although results of intestinal permeability were inconclusive Tm, but not other type of gluten, was clinically well tolerated. The aim of the present study was to assess safety of 60 days of administration of Tm (100 grams of water biscuits per day accounting for about 6 grams of gluten from Tm) as judged on clinical, serological and histological parameters in Celiac Disease patients on remission after 1 year of GFD.
3 schema:endDate 2011-08-01T00:00:00Z
4 schema:keywords Gram
5 Organization and Administration
6 Phase II
7 TM
8 Triticum
9 biscuit
10 celiac disease
11 ex vivo study
12 gluten
13 gluten-free diet
14 intestinal permeability
15 parameter
16 patient
17 preliminary study
18 present study
19 remission
20 reported result
21 safety
22 safety profile
23 single administration
24 symptom
25 toxicity
26 vitro
27 schema:name Phase II Study on Safety of 60 Days Administration of Triticum Monococcum in Patients With Celiac Disease on Remission in Gluten Free Diet
28 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT02220166
29 schema:sdDatePublished 2019-03-07T15:25
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher N3b3535d6190d4547ac27273d28eb9cf5
32 schema:sponsor https://www.grid.ac/institutes/grid.412725.7
33 https://www.grid.ac/institutes/grid.7637.5
34 schema:startDate 2010-11-01T00:00:00Z
35 schema:subjectOf sg:pub.10.1186/1471-230x-13-92
36 schema:url https://clinicaltrials.gov/show/NCT02220166
37 sgo:license sg:explorer/license/
38 sgo:sdDataset clinical_trials
39 rdf:type schema:MedicalStudy
40 N3b3535d6190d4547ac27273d28eb9cf5 schema:name Springer Nature - SN SciGraph project
41 rdf:type schema:Organization
42 anzsrc-for:3103 schema:inDefinedTermSet anzsrc-for:
43 rdf:type schema:DefinedTerm
44 sg:pub.10.1186/1471-230x-13-92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030901615
45 https://doi.org/10.1186/1471-230x-13-92
46 rdf:type schema:CreativeWork
47 https://www.grid.ac/institutes/grid.412725.7 schema:Organization
48 https://www.grid.ac/institutes/grid.7637.5 schema:Organization
 




Preview window. Press ESC to close (or click here)


...